Suggestions
Idioma
Journal Information

Most often read

12256
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH)
Carlos Sérgio Chiattone, Fernanda de Morais Marques, Valeria Buccheri, Mihoko Yamamoto, Sergio Costa Fortier, Maura Rosane Valerio Ikoma-Colturato, Nelson Hamerschlak, Vera Lucia de Piratininga Figueiredo, ... Brazilian Group of Chronic Lymphocytic Leukemia
Hematol Transfus Cell Ther. 2025;47: 103822
12256
Full text access
7420
DEFICIÊNCIA DE G6PD ‒ MUITAS DÚVIDAS A ESCLARECER
CG Costa
Hematol Transfus Cell Ther. 2025;47 Supl 3: 105059
7420
Full text access
5927
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?
Daniel Mazza Matos
Hematol Transfus Cell Ther. 2025;47: 103668
5927
Full text access
5650
Blood storage effect of G6PD on RBC quality
Andrew Evans Cobbinah, Benedict Sackey, Mina Ofosu, Herbert Ekoe Dankluvi, Stephen Opoku, Ampa Davis Frank
Hematol Transfus Cell Ther. 2025;47: 103733
5650
Full text access
5559
When innovation meets patient blood management – a new way to see bleeding
Guilherme Rabello, Rosangela Monteiro, Bianca Meneghini, Fabio Biscegli Jatene
Hematol Transfus Cell Ther. 2025;47: 103691
5559
Full text access
5497
An approach to autologous stem cell mobilization: trying to define good mobilizers
Sara Montolio Chiva, Paula Gomez Fernandez, Antonio Manuel Gutiérrez Garcia, Maria del Carmen Ballester Ruiz, Antonia Sampol Mayol, Albert Perez Montaña
Hematol Transfus Cell Ther. 2025;47: 103688
5497
Full text access
5256
Optimization of hydroxyurea in sickle cell disease in Brazil
Clarisse Lobo, Ana Cristina Silva-Pinto, Rodolfo Delfini Cançado
Hematol Transfus Cell Ther. 2025;47: 103826
5256
Full text access
4626
From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy
Frank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, Euler Manenti, Juliana Soares, Mizianne Garcia Freitas, Juliane Dantas Seabra-Garcez, Alexandre Manoel Varela, ... Ariane Vieira Scarlatelli Macedo
Hematol Transfus Cell Ther. 2025;47: 103693
4626
Full text access
4223
Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?
Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, Vanessa Tonetto Marques Galves, Hilton Marcos Alves Ricz, Tatiane Cristina Ferrari, Renato Luiz Guerino Cunha, Belinda Pinto Simões, Leandro Dorigan de Macedo
Hematol Transfus Cell Ther. 2025;47: 103687
4223
Full text access
4204
Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review
Isabela de Oliveira Araujo, Lucas Fernandes Suassuna, Isabela Lima dos Santos, Daniela de Oliveira Werneck Rodrigues
Hematol Transfus Cell Ther. 2025;47: 103849
4204
Full text access
4031
Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles
Carolina Kymie Vasques Nonaka, Zaquer Suzana Munhoz Costa-Ferro, Ana Carolina Palmeira Arraes, Thamires Lopes Weber, Luciana Souza de Aragão França, Katia Nunes Silva, Bruno Solano de Freitas Souza
Hematol Transfus Cell Ther. 2025;47: 103727
4031
Full text access
3984
Overall survival in multiple myeloma in Brazil: A cohort of 16 years
Deborah Marta do Santos Oliveira, Isabela Cristina Menezes de Freitas, Wallace Mateus Prata, Isabella Zuppo Laper, Pâmela Santos Azevedo, Adriano de Paula Sabino, Marisa Yurico Itonaga, Carmino Antonio de Souza, ... Augusto Afonso Guerra Junior
Hematol Transfus Cell Ther. 2025;47: 103962
3984
Full text access
3745
Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review
Alessandra NL Prezotti, Débora MC Rocha, Endi L. Galvão, Thaís Gimenez, Leo Sekine, Rodrigo A. Ribeiro, Elisa Sobreira
Hematol Transfus Cell Ther. 2025;47: 103736
3745
Full text access
3697
Updating the Brazilian clinical practice guidelines for sickle cell disease: Recommendations and development process
Ludmila Peres Gargano, Mariana Millan Fachi, Layssa Andrade Oliveira, Clarisse Lobo, Katharina Nelly Tobos Melnikoff, Selma Soriano, Marta da Cunha Lobo Souto Maior, Meline Rossetto Kron-Rodrigues, ... Rosa Camila Lucchetta
Hematol Transfus Cell Ther. 2025;47: 103964
3697
Full text access
3585
Complex somatic mutation landscape in myeloid cells in a patient with VEXAS syndrome: First Brazilian case report
Fabíola Reis de Oliveira, Adriane Souza Lima, Carlos Roberto Faria, Thaise Oliveira Quaresma, Marcio M. Mourani, Lauro Wichert-Ana, Paulo Louzada, Fernanda Gutierrez-Rodrigues, ... Rodrigo T. Calado
Hematol Transfus Cell Ther. 2025;47: 103686
3585
Full text access
3579
Assessing the contribution of myelofibrosis to a leukoerythroblastic blood picture
Stephen E. Langabeer
Hematol Transfus Cell Ther. 2025;47: 103735
3579
Full text access
3553
Lack of association between the TMPRSS6 gene polymorphism (rs855791) and anemia: a comprehensive meta-analysis
Jethendra Kumar Muruganantham, Ramakrishnan Veerabathiran
Hematol Transfus Cell Ther. 2025;47: 103737
3553
Full text access
3523
STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancy
Indranil Dey, Sushant Vinarkar, Mayur Parihar, Deepak Kumar Mishra
Hematol Transfus Cell Ther. 2025;47: 103726
3523
Full text access
3516
Impact of blueberry extract on hematological response in phenylhydrazine-induced hemolytic anemia
Daniela Drosdowski, Patrick Türck, Silvio Tasca, Gabriel de Lima Rosa, Edson Fernando Muller Guzzo, Sara Elis Bianchi, Adriana Simon Coitinho, Cristina Campos Carraro, ... Alex Sander da Rosa Araujo
Hematol Transfus Cell Ther. 2025;47: 103744
3516
Full text access
Idiomas
Hematology, Transfusion and Cell Therapy